HomeAgentsHow it worksOur workBlogRegen NewsAbout
Book a demo
Regen News by ClinicTech

The weekly briefing for regenerative medicine clinic owners.

Research, regulatory moves, and market shifts that affect your clinic. We read the papers, track the trials, and follow the money so you don't have to.

200+
Subscribers
Weekly
Every Monday
Free
Always
Subscribe to Regen News
Free. No spam. Unsubscribe anytime.
This Week in Regen Med
RegulatoryJapan

Japan grants world-first approval for two stem cell therapies

Japan has approved iPSC-derived treatments for Parkinson's disease and severe heart failure, marking the first full regulatory approval for stem cell-based regenerative therapies anywhere in the world.
Science.org
Why this matters for your clinic
This sets the regulatory precedent that every clinic owner has been watching. If Japan's approval framework holds, expect similar pathways to open in the US and EU within 24 months. Clinics offering MSC or PRP treatments should be positioning now for the credibility wave this creates.
ResearchUS

Stem cells provide a potent new treatment for frailty in the elderly

A Nature study shows elderly patients with frailty increased endurance significantly after a single dose of mesenchymal stem cells, with results lasting over 12 months.
Nature
Why this matters for your clinic
Frailty is a massive addressable market. One in four people over 50 are affected. If your clinic treats aging-related conditions, this is the study to reference in patient-facing content and consultation scripts.

Stem cell transplant without toxic preparation treats sickle cell disease

Stanford Medicine's Phase 1 trial demonstrates that an antibody-based preparation can replace toxic chemotherapy in stem cell transplants, dramatically reducing side effects.
Clinical TrialUSStanford Medicine

New bioreactor produces 40 million immune cells per week from stem cells

Researchers have developed a cost-effective bioreactor that turns stem cells into human macrophages at industrial scale, opening new possibilities for off-the-shelf cell therapies.
ResearchUSPhys.org

UCLA reprogram stem cells to create renewable cancer-fighting T cells

First-in-human clinical trial shows that combining genetically engineered T cells with stem cells can produce cancer-fighting immune cells in humans, with durable responses.
Clinical TrialUSUCLA Health

First-ever in-utero stem cell therapy for spina bifida is safe

UC Davis researchers safely performed the world's first spina bifida treatment combining fetal surgery with placenta-derived stem cells in six patients.
Clinical TrialUSUC Davis Health

Stem cell engineering breakthrough paves way for next-generation living drugs

UBC researchers discover how to grow specialized immune cells for more accessible off-the-shelf cell therapies to treat cancer, autoimmune disorders, and infections.
ResearchCanadaUBC Medicine

Regenerative medicine marketing outpaces the science, experts warn

STAT News reports that marketing claims from regenerative medicine clinics are increasingly outpacing peer-reviewed evidence, raising concerns about patient safety and regulatory scrutiny.
IndustryUSSTAT News

NIH proposes shift in embryonic stem cell research to 'put patients first'

The NIH is seeking public input on redirecting embryonic stem cell funding toward technologies with better clinical outcomes, including iPSC-based approaches.
RegulatoryUSNIH

Don't miss a week.

The news that matters for regenerative medicine clinic owners. Delivered every Monday.

Regen News by ClinicTech
BlogAboutclinictech.io